Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Asfotase Alfa in Children with HPP
NCT01203826Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Apr 2010
- Primary completion
- Jun 2016
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Primary endpoint: Radiographic Global Impression of Change at 72 months. Started Apr 2010; status: completed.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT01203826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203826.